ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

Remaining DCT Recompetitions

November 7, 1980

TCGA Researchers Discover Stomach Cancer Falls Into Four Distinct Molecular Subtypes

August 29, 2014

In Brief: Hammond Honored By ACS; SEER Celebrates 20th Anniversary With Symposium Dec. 8

December 3, 1993

Funding Opportunities: NIAID seeks New Investigator, Risky Research Proposals

March 28, 1997

ONF Seeks Applications For Grants In Fatigue

March 31, 1995